- CONMED press release ( NYSE: CNMD ): Q2 Non-GAAP EPS of $0.76 beats by $0.01 .
- Revenue of $277.19M (+23.1% Y/Y) beats by $2.97M .
- The Company lowered its revenue guidance for the full year 2022 and now expects revenue between $1.095 billion and $1.140 billion compared to its prior guidance of between $1.105 billion and $1.150 billion vs. $1.12B.
- The Company now expects full-year 2022 adjusted diluted net earnings per share in the range of $3.40 to $3.55, down from the prior range of $3.50 to $3.65. $3.50 consensus.
For further details see:
CONMED Non-GAAP EPS of $0.76 beats by $0.01, revenue of $277.19M beats by $2.97M